STOCK TITAN

embecta to Participate in Investor Events

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Embecta Corp. (EMBC), a global diabetes care company, has announced its participation in two upcoming investor events. The company will attend the 2024 Wells Fargo Healthcare Conference on September 4, hosting one-on-one investor meetings at the Encore Boston Harbor Hotel. Additionally, embecta will participate in the 2024 Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, where management will host a fireside session at 2:35 p.m. ET at the Marriott Marquis in New York.

These events provide opportunities for investors to engage with embecta's management and gain insights into the company's operations and strategy. Audio webcasts of the presentations will be available on embecta's investor relations website under the 'News & Events' section, allowing wider access to the company's updates and discussions.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

+6.14% News Effect

On the day this news was published, EMBC gained 6.14%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events:

2024 Wells Fargo Healthcare Conference

• Management will host one-on-one investor meetings on Wednesday, September 4, 2024, at the Encore Boston Harbor Hotel in Boston.

2024 Morgan Stanley 22nd Annual Global Healthcare Conference

• Management will host a fireside session on Thursday, September 5, 2024, at 2:35 p.m. Eastern Time (ET) at the Marriott Marquis in New York. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at https://investors.embecta.com.

About embecta 
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships, and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedInFacebookInstagram and Twitter.


Contacts:

MediaInvestors
Christian GlazarPravesh Khandelwal
Sr. Director, Corporate CommunicationsVP, Head of Investor Relations
908-821-6922551-264-6547
Contact Media Relations Contact IR

FAQ

What investor events will embecta (EMBC) participate in during September 2024?

Embecta (EMBC) will participate in two investor events in September 2024: the Wells Fargo Healthcare Conference on September 4 and the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5.

Where can investors access the audio webcasts of embecta's (EMBC) presentations at the investor events?

Investors can access the audio webcasts of embecta's (EMBC) presentations under the 'News & Events' section of the company's investor relations website at https://investors.embecta.com.

What type of meetings will embecta (EMBC) host at the 2024 Wells Fargo Healthcare Conference?

Embecta (EMBC) will host one-on-one investor meetings at the 2024 Wells Fargo Healthcare Conference on September 4, 2024, at the Encore Boston Harbor Hotel in Boston.

When and where will embecta (EMBC) host its fireside session at the Morgan Stanley Global Healthcare Conference?

Embecta (EMBC) will host a fireside session at the Morgan Stanley Global Healthcare Conference on Thursday, September 5, 2024, at 2:35 p.m. Eastern Time at the Marriott Marquis in New York.
Embecta Corp

NASDAQ:EMBC

EMBC Rankings

EMBC Latest News

EMBC Latest SEC Filings

EMBC Stock Data

702.25M
58.35M
0.47%
101.61%
5.13%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
WILMINGTON